D. Flaim

Safety and efficacy of ezetimibe added on to rosuvastatin 5 or 10 mg versus up-titration of rosuvastatin in patients with hypercholesterolemia (the ACTE Study).

H. Bays, M. Davidson, C. Jones-Burton, 2011, The American journal of cardiology.

Efficacy and Safety of Ezetimibe Plus Rosuvastatin Versus Rosuvastatin Up-Titration in Hypercholesterolemic Patients at Risk for Atherosclerotic Coronary Heart Disease

H. Bays, M. Davidson, C. Jones-Burton, 2011 .

Safety and efficacy of ezetimibe/simvastatin combination versus atorvastatin alone in adults ≥65 years of age with hypercholesterolemia and with or at moderately high/high risk for coronary heart disease (the VYTELD study).

J. Foody, A. Adewale, W. Brown, 2010, The American journal of cardiology.

Randomized, double-blind, phase 3 trial of first-line pembrolizumab + platinum doublet chemotherapy (chemo) ± lenvatinib in patients (pts) with metastatic nonsquamous non–small-cell lung cancer (NSCLC): LEAP-006.

R. Herbst, M. Nishio, M. Reck, 2019, Journal of Clinical Oncology.